These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 15492621)
1. Risks of intravitreous injection: a comprehensive review. Jager RD; Aiello LP; Patel SC; Cunningham ET Retina; 2004 Oct; 24(5):676-98. PubMed ID: 15492621 [TBL] [Abstract][Full Text] [Related]
2. [Intravitreous injection: retrospective study on 2028 injections and their side effects]. Angulo Bocco MC; Glacet-Bernard A; Zourdani A; Coscas G; Soubrane G J Fr Ophtalmol; 2008 Sep; 31(7):693-8. PubMed ID: 18971854 [TBL] [Abstract][Full Text] [Related]
3. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting. Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735 [TBL] [Abstract][Full Text] [Related]
6. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Kuppermann BD; Thomas EL; de Smet MD; Grillone LR; Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510 [TBL] [Abstract][Full Text] [Related]
8. Complications of intravitreal injection of triamcinolone acetonide. Ozkiriş A; Erkiliç K Can J Ophthalmol; 2005 Feb; 40(1):63-8. PubMed ID: 15825532 [TBL] [Abstract][Full Text] [Related]
9. Minimizing the risk of endophthalmitis following intravitreous injections. Ta CN Retina; 2004 Oct; 24(5):699-705. PubMed ID: 15492622 [TBL] [Abstract][Full Text] [Related]
10. [Technique of intravitreal drug injection for therapy of vitreoretinal diseases]. Rodrigues EB; Maia M; Penha FM; Dib E; Bordon AF; Magalhães Júnior O; Farah ME Arq Bras Oftalmol; 2008; 71(6):902-7. PubMed ID: 19169531 [TBL] [Abstract][Full Text] [Related]
11. [Intravitreal injections of corticoids]. Demols P Bull Soc Belge Ophtalmol; 2007; (304):117-23. PubMed ID: 17718236 [TBL] [Abstract][Full Text] [Related]
12. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. ; D'Amico DJ; Masonson HN; Patel M; Adamis AP; Cunningham ET; Guyer DR; Katz B Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal Injection--Technique and Safety. Lai TY; Liu S; Das S; Lam DS Asia Pac J Ophthalmol (Phila); 2015; 4(6):321-8. PubMed ID: 26649760 [TBL] [Abstract][Full Text] [Related]
14. Quality assessment of cataract surgery in Denmark - risk of retinal detachment and postoperative endophthalmitis. Bjerrum SS Acta Ophthalmol; 2015 Mar; 93 Thesis 2():1-15. PubMed ID: 25712600 [TBL] [Abstract][Full Text] [Related]
15. Complications of intravitreal steroid injections. Reichle ML Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone acetonide: a change in a paradigm. Jonas JB Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379 [TBL] [Abstract][Full Text] [Related]
17. Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections. Sharma S; Johnson D; Abouammoh M; Hollands S; Brissette A Can J Ophthalmol; 2012 Jun; 47(3):275-9. PubMed ID: 22687306 [TBL] [Abstract][Full Text] [Related]
18. Ocular findings in leprosy. Shields JA; Waring GO; Monte LG Am J Ophthalmol; 1974 Jun; 77(6):880-90. PubMed ID: 4365663 [No Abstract] [Full Text] [Related]
19. Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Jonas JB; Spandau UH; Schlichtenbrede F Eye (Lond); 2008 Apr; 22(4):590-1. PubMed ID: 18292795 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]